Skip to main content
Clinical Trials/NCT01321593
NCT01321593
Completed
Not Applicable

Comparison of the Hemoglobin Results Obtained With the "Orsense NBM-200MP" Device and the Clinical Laboratory

Hopital Foch1 site in 1 country300 target enrollmentStarted: February 2011Last updated:
ConditionsEmergency

Overview

Phase
Not Applicable
Status
Completed
Enrollment
300
Locations
1
Primary Endpoint
Hemoglobin measurement using the "Orsense NBM-200MP" device

Overview

Brief Summary

The purpose of this study is to compare the hemoglobin results obtained with the "Orsense NBM-200MP" device and the Clinical Laboratory.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • emergency unit patients requiring an hemoglobin determination

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Hemoglobin measurement using the "Orsense NBM-200MP" device

Time Frame: 4 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials